ATP Assays Market Size Worth USD 7.23 Billion by 2034 | CAGR: 7.68%

The ATP assays market size is expected to reach USD 7.23 billion by 2034, according to a new study by Polaris Market Research. The report “ATP Assays Market Share, Size, Trends, Industry Analysis Report By Type [Luminometric ATP Assays, Enzymatic ATP Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, Cell-based ATP Assays, Others], By Application, By End Use, By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

ATP (adenosine triphosphate) assays are biochemical tests used to measure the concentration of ATP in biological samples, providing insights into cellular metabolism, viability, and energy status. ATP, the primary energy carrier for cellular processes, is essential in drug discovery informatics, microbiology, environmental monitoring, and cancer research.

The principle behind ATP assays relies on the enzymatic conversion of ATP to light, typically using luciferase, an enzyme derived from fireflies. In the presence of ATP, luciferase catalyzes the oxidation of luciferin, emitting bioluminescence that is proportional to the ATP concentration. This reaction is highly sensitive, allowing detection of even femtomole levels of ATP.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/atp-assays-market/request-for-sample

ATP assays are widely used in cell viability and cytotoxicity studies. In drug development, they help screen compounds for toxic effects by measuring ATP depletion in treated cells, indicating cell death or metabolic inhibition. Similarly, in cancer research, ATP assays evaluate the efficacy of chemotherapeutic agents by monitoring ATP levels in tumor cells. Microbial viability testing also employs ATP assays to detect contamination in water, food, and pharmaceuticals, as living microorganisms contain measurable ATP.

Top of FormATP Assays Market Report Highlights

• In terms of type, the luminometric ATP assays segment held 33.12% of revenue share in 2024 due to its widespread adoption across pharmaceutical, biotechnology, and food and beverage industries.
• Based on application, the drug discovery segment accounted for 34.17% of the revenue share in 2024, driven by the increasing demand for rapid and reliable methods to evaluate cell viability, cytotoxicity, and compound efficacy.
• In terms of end use, the pharmaceutical and biotechnology companies segment dominated the revenue share in 2024 by holding 40.23% of the share. This is attributed to the increasing reliance on cellular energy measurements during drug screening, toxicity testing, and evaluations of therapeutic efficacy.
• North America accounted for a 38.15% share of the global ATP assays market revenue in 2024. This dominance is attributed to the region's strong biotechnology and pharmaceutical industries, which rely on ATP detection for drug development, toxicity testing, and cell viability studies.
• The market in Europe is projected to hold a substantial market share in 2034 due to strict regulatory frameworks that mandate ATP-based hygiene monitoring.
• The industry in Asia Pacific is projected to grow at the fastest pace in the coming years, owing to expanding pharmaceutical and biotechnology industries, particularly in China, India, and Japan.
• A few global key players in the ATP assays market include Abcam plc; Becton, Dickinson and Company (BD); Biomerieux SA; Biotium; Danaher Corporation; Lonza Group Ltd.; Merck KGaA; PerkinElmer Inc.; Promega Corporation; Quest Diagnostics Incorporated; Reaction Biology; and Thermo Fisher Scientific.

Polaris Market Research has segmented the ATP assays market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Luminometric ATP Assays
• Enzymatic ATP Assays
• Bioluminescence Resonance Energy Transfer (BRET) ATP Assays
• Cell-based ATP Assays
• Others

By Application Mode Outlook (Revenue, USD Billion, 2020–2034)

• Drug Discovery and Development
• Clinical Diagnostics
• Environmental Testing
• Food Safety and Quality Testing
• Others

By End Use Outlook (Revenue, USD Billion, 2020–2034)

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Hospital and Diagnostics Laboratories

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America